DR. KATHERINE ELEANOR DERTZ M.D.
Prescription History 1104276021
Obstetrics & Gynecology in Washington, DC

Active since June 22, 2016PECOS Enrolled
2120 L ST NW STE 700, WASHINGTON, DC 20037(202) 331-9293 Get Directions

NPPES record last updated: March 3, 2025. Verified against the NPPES registry weekly; last sync: August 09, 2026.

Record update history: Mar 3, 2025, Oct 25, 2016, Jun 22, 2016 (3 updates tracked since 2016).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. KATHERINE ELEANOR DERTZ M.D., an active Obstetrics & Gynecology specialist practicing in Washington, DC. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 14 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
14
Total Claims
28
30-Day Fills
Estradiol
Most Prescribed · 14 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. KATHERINE ELEANOR DERTZ M.D. in 2023, with prescription volumes, average cost per fill, and DC state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other DC PrescribersVs. DC Avg
Estradiol14$83.34▼ below DC avg Less than typical

About Estradiol: This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2023, this provider wrote 14 Medicare prescriptions for Estradiol, about a third of the volume of the typical District Of Columbia prescriber of this medication (38). Medicare paid an average of $83.34 per fill, versus $104.18 statewide.

How often this provider prescribes it

This provider
14
DC average
38.0

This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$83.34
DC average
$104.18

This provider's average cost per fill is below the DC average for this medication.

28
30-Day Fills
standardized to 30-day supplies
840
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average DC prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the DC average cost per fill.

About this data. The prescription history for DR. KATHERINE ELEANOR DERTZ M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Washington, DC practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among DC prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.